Generex Makes Podium Presentation of Vaccine Technology Platform With Cancer & Influenza Updates at PepTalk 2010
January 19, 2010 09:30 ET
|
Generex Biotechnology Corp.
WORCESTER, Mass., Jan. 19, 2010 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com) announced today the presentation of the immuno-therapeutics vaccine technology...
Generex Biotechnology Corporation to Present at the OneMedForum 2010 Conference
January 13, 2010 10:33 ET
|
Generex Biotechnology Corp.
WORCESTER, Mass., Jan. 13, 2010 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of...
Generex Receives Over $800,000 in Initial Purchase Orders for Crave-NX(TM) 7-Day Diet Aid Spray
January 13, 2010 09:30 ET
|
Generex Biotechnology Corp.
WORCESTER, Mass., Jan. 13, 2010 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of...
Major U.S. Pharmacy Chain to Market Generex's Crave-NX(TM) 7-Day Diet Aid Spray Throughout Its Nationwide Network of Over 7,000 Stores
January 11, 2010 09:00 ET
|
Generex Biotechnology Corp.
WORCESTER, Mass., Jan. 11, 2010 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of...
Generex: a Year in Review; Setting the Stage for a Year of Progress (Part Three)
January 08, 2010 09:00 ET
|
Generex Biotechnology Corp.
By Dr. Joseph Rubinfeld, Chief Scientific Advisor
A Three Part Article on the Accomplishments of 2009
and the Potential of 2010 and Beyond
Part...
Generex: a Year in Review; Setting the Stage for a Year of Progress (Part Two)
January 07, 2010 09:00 ET
|
Generex Biotechnology Corp.
By Dr. Joseph Rubinfeld, Chief Scientific Advisor
A Three Part Article on the Accomplishments of 2009
and the Potential of 2010 and Beyond
...
Generex: a Year in Review; Setting the Stage for a Year of Progress
January 06, 2010 09:00 ET
|
Generex Biotechnology Corp.
By Dr. Joseph Rubinfeld, Chief Scientific Advisor
A Three Part Article on the Accomplishments of 2009
and the Potential of 2010 and Beyond
Part...
Generex MENA Supplies Products to New International Territories
December 17, 2009 08:30 ET
|
Generex Biotechnology Corp.
WORCESTER, Mass., Dec. 17, 2009 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of...
Generex Clarifies Previous Announcement of Breast Cancer Study Interim Results
December 15, 2009 09:15 ET
|
Generex Biotechnology Corp.
WORCESTER, Mass., Dec. 15, 2009 (GLOBE NEWSWIRE) -- On December 14, 2009, Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com) issued a press release announcing the presentation of...
Generex Presents Encouraging Interim Results of Phase II Breast Cancer Study
December 14, 2009 09:30 ET
|
Generex Biotechnology Corp.
WORCESTER, Mass., Dec. 14, 2009 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com) today announced presentation of interim results from a Phase II efficacy study of...